Linked-in Link Twitter Link

Innova Portfolio Company Completes £1.5M Oversubscribed Funding Round - Biotangents to Accelerate Roll Out of Livestock Disease Diagnostic Product

May 06, 2019

Biotangents, a Scottish medical diagnostics business, has secured £1.5m of new investment following the completion of a second fundraising round.

Vitamica Announce Successful First Round of Funding

Oct 10, 2018

By Amy Ricketts, a Summer student, doing work experience for Innova Partnerships

Innova Partnerships Appointed by Invest Northern Ireland to Support Irish Company Growth

Jun 01, 2018

Innova Partnerships is pleased to announce that it has been appointed by Invest Northern Ireland to support the growth of exports to the rest of the UK by life and health science companies across the region for a three-year period.

Invest Northern Ireland is the economic development agency for Northern Ireland. They help businesses compete successfully in international markets through a variety of support mechanisms. During 2016/17, over £200m was invested in R&D and wider innovation and created an additional 5,900 new jobs.

Commenting, Innova Partnerships’ Chief Operating Officer, Joanne Hagerty said, “We are delighted to have the chance to mirror the success we have had in Scotland in Northern Ireland. Earlier this year the Northern Ireland Assembly committed…

Innova Partnerships’ Latest Portfolio Company, Vitamica Ltd, Spun Out of the University of Bristol

Apr 20, 2018

Innova Partnerships is pleased to announce that its latest portfolio company, Vitamica Ltd, is a spin out from the University of Bristol.

The Company has been formed to commercialise the ground-breaking work of Dr Massimo Antognozzi, from the Department of Physics, who has used optical analysis of live bacteria to measure changes in their response to antibiotics. The technique has demonstrated a fast and accurate technique that can be used to assess antimicrobial resistance of bacteria. This will open up applications for personalised medicine and should help stem the over use of antibiotics.

The University of Bristol and Innova Partnerships worked together to evaluate the opportunity which led to the formation of the spin out. Over a period of 9 months Innova worked with…

Biotangents Secures £326,000 in Equity Finance

Dec 21, 2017

Scottish based Biotangents Ltd are developing timely diagnostics to improve livestock welfare.  Recently, the Company closed an equity financing round of £326,000 that will be used to progress their pen-side infectious disease test. The investment came from Kelvin Capital members and was supported by Innova Partnerships.

Commenting, Innova’s founder, Prof Steve Howell, said “The team at Biotangents have made significant progress over the last year and this investment will allow them to speed up product development.”

Biotangents CEO, Alan Hale, added “We have some exceptional individuals and founders, in Andy and Lina. Together, we are focussed on bringing to market cost-effective solutions to support livestock disease management and look forward to an exciting year ahead.”

The…

Biotangents; Primed for Success

Oct 19, 2017

By Becca Hardman Carter, an Advanced Higher student doing work experience with Innova Partnerships

Dr Andrew McNair Appointed as Innova Partnerships Managing Director

Jul 21, 2017

Innova Partnerships is pleased to announce the appointment of Dr Andrew McNair as Managing Director of the business, effective immediately.

Innova Partnerships Exits Portfolio Company: Innova Biosciences Acquired by SYGNIS AG

Jun 21, 2017

Innova Partnerships' portfolio company, Innova Biosciences Ltd, has been acquired successfully by German listed company SYGNIS AG [LIO1.DE].

Portfolio Company, Relaymed, Signs Strategic Alliance with Siemens Healthineers to Seamlessly Deliver Point-of-Care Test Results to HER Systems

May 18, 2017

Siemens Healthineers announced today its strategic alliance with Relaymed to bring customers secure, cloud-based connectivity for Siemens DCA Vantage© Analyzer and CLINITEK Status© point-of-care (POC) instruments. With Relaymed integration, patient test results are automatically and instantly sent from the POC instruments to physician-office electronic health record (EHR) systems, reducing the likelihood of human error by eliminating the manual input step. Through its collaboration with Relaymed, Siemens Healthineers aims to enable healthcare providers to meet their current challenges and excel in their respective environments.

 “Our exclusive agreement with Relaymed means an extension of our connectivity offerings for Siemens Healthineers point-of-care instruments to meet the needs…

Portfolio Company, Innova Biosciences, valued at €12.8 Million to be Acquired by Sygnis AG

May 08, 2017

Innova Partnerships' portfolio company, Innova Biosciences Ltd, is to be acquired by German listed company Sygnis AG [LIO1.DE] at a €12.8M valuation.